Treatments differ widely in these mimics
Why precise diagnosis matters
How to tell the difference and why it matters
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings from a recent randomized trial investigating mepolizumab
A better outlook
Two trials provide important advances in treatment
An important goal of the Center for Vasculitis Care and Research
Collaboration studying immunologic perturbations
Research Points to Antibodies as Potential Marker
Advertisement
Advertisement